Abstracts tagged "SLE and classification criteria"

Abstract Number: 2928 • 2018 ACR/ARHP Annual Meeting
Validation of New Systemic Lupus Erythematosus Classification Criteria
Martin Aringer¹, Karen Costenbader², Ralph Brinks³, Dimitrios Boumpas⁴, David Daikh⁵, David Jayne⁶, Diane L. Kamen⁷, Marta Mosca⁸, Rosalind Ramsey-Goldman⁹, Josef S. Smolen¹⁰, David Wofsy¹¹, Betty Diamond¹², Søren Jacobsen¹³, W. Joseph McCune¹⁴, Guillermo Ruiz-Irastorza¹⁵, Matthias Schneider¹⁶, Murray Urowitz¹⁷, George Bertsias¹⁸, Bimba Hoyer¹⁹, Nicolai Leuchten¹, Chiara Tani²⁰, Sara K. Tedeschi²¹, Zahi Touma²², Branimir Anic²³, Florence Assan²⁴, Tak Mao Chan²⁵, Ann E. Clarke²⁶, Peggy Crow²⁷, László Czirják²⁸, Andrea Doria²⁹, Winfried Graninger³⁰, Bernadett Halda-Kiss²⁸, Sarfaraz A. Hasni³¹, Peter M. Izmirly³², Michelle Jung³³, Gabor Kumanovics²⁸, Xavier Mariette²⁴, Ivan Padjen²³, JM Pego-Reigosa³⁴, Juanita Romero-Díaz³⁵, Iñigo Rúa-Figueroa³⁶, Raphaele Seror³⁷, Georg Stummvoll³⁸, Yoshiya Tanaka³⁹, Maria Tektonidou⁴⁰, Carlos Vasconcelos⁴¹, Edward M Vital⁴², Daniel J. Wallace⁴³, Sule Yavuz⁴⁴, Raymond P. Naden⁴⁵, Thomas Dörner⁴⁶ and Sindhu Johnson⁴⁷, ¹Medicine III, University Medical Center and Faculty of Medicine TU Dresden, Dresden, Germany, ²Rheumatology, Immunology and All, Brigham & Women's Hospital, Boston, MA, ³Department of Rheumatology & Hiller Research Unit, Heinrich-Heine University, Düsseldorf, Germany, ⁴University of Athens, Athens, Greece, ⁵Rheumatology, UCSF and VA Medical Center, San Francisco, CA, ⁶Department of Medicine, University of Cambridge, Cambridge, United Kingdom, ⁷Medicine/Rheumatology & Immunology, Medical University of South Carolina, Charleston, SC, ⁸Rheumatology Unit, University of Pisa, Pisa, Italy, ⁹FSM, Northwestern University, Chicago, IL, ¹⁰Division of Rheumatology, Department of Medicine 3, Medical University of Vienna, Vienna, Austria, ¹¹University of California San Francisco, San Francisco, CA, ¹²Autoimmune Musculoskeletal and Hematopoietic Diseases, The Feinstein Institute for Medical Research, Manhasset, NY, ¹³University of Copenhagen, Copenhagen, Denmark, ¹⁴Int Med/ Rheum, University of Michigan, Ann Arbor, MI, ¹⁵Autoimmune Diseases Research Unit, BioCruces, Hospital Universitario Cruces, Baracaldo, Spain, ¹⁶Department and Hiller Research Center for Rheumatology, Heinrich-Heine University, Duesseldorf, Germany, ¹⁷University of Toronto Lupus Research Program, Toronto Western Hospital, Toronto, ON, Canada, ¹⁸Department of Rheumatology, Clinical Immunology and Allergy, University of Crete, School of Medicine, Heraklion, Greece, ¹⁹University of Schleswig-Holstein, Kiel, Germany, ²⁰University of Pisa, Pisa, Italy, ²¹Rheumatology Immunology & Allergy, Brigham & Women's Hospital, Boston, MA, ²²University of Toronto, Toronto Western Hospital, Toronto, ON, Canada, ²³Department of Internal Medicine, University Hospital Zagreb and University of Zagreb School of Medicine, Zagreb, Croatia, ²⁴Université Paris Sud, Paris, France, ²⁵University of Hong Kong, Hong Kong, Hong Kong, ²⁶Department of Medicine, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada, ²⁷Department of Medicine, Hospital for Special Surgery, New York, NY, ²⁸Rheumatology and Immunology, University of Pécs, Pécs, Hungary, ²⁹University and Azienda Ospedaliera of Padova, Padova, Italy, ³⁰Rheumatology and Immunology, Medical University of Graz, Graz, Austria, ³¹Lupus Clinical Research Program, Office of the Clinical Director, NIH/NIAMS, Bethesda, MD, ³²NYU Langone Health, New York, NY, ³³University of Calgary, Calgary, AB, Canada, ³⁴Complexo Hospitalario Universitario de Vigo, Vigo, Spain, ³⁵Immunology and Rheumatology, Instituto Nacional de Ciencias Medicas y Nutricion, Mexico City, Mexico, ³⁶Rheumatology Division, Hospital Doctor Negrin, Las Palmas GC, Spain, ³⁷Center for Immunology of Viral Infections and Autoimmune Diseases, Assistance Publique – Hôpitaux de Paris, Hôpitaux Universitaires Paris-Sud, Le Kremlin-Bicêtre, Université Paris Sud, INSERM, Paris, France, Paris, France, ³⁸Rheumatology, Medical University Vienna, Vienna, Austria, ³⁹University of Occupational and Environmental Health, Kitakyushu, Japan, ⁴⁰Rheumatology Unit, 1st Dept. of Propaedeutic Internal Medicine, Joint Academic Rheumatology Program, Athens University Medical School, Athens, Greece, ⁴¹Centro Hospitalar do Porto, University of Porto, Porto, Portugal, ⁴²University of Leeds, Leeds, United Kingdom, ⁴³Division of Rheumatology, Cedars-Sinai Medical Center, Los Angeles, CA, ⁴⁴Department of Rheumatology, Marmara University, Istanbul, Turkey, ⁴⁵New Zealand Ministry of Health, New Zealand Ministry of Health, Auckland, New Zealand, ⁴⁶Charité Universitätsmedizin Berlin, Berlin, Germany, ⁴⁷Rheumatology, Mount Sinai Hospital and University Health Network, Toronto, ON, Canada
Background/Purpose: Correct classification of patients with systemic lupus erythematosus (SLE) is critical for clinical trials and clinical and translational science. The ACR 1997 criteria were…
Abstract Number: 789 • 2016 ACR/ARHP Annual Meeting
Use of Nominal Group Technique to Determine Candidate Items for SLE Classification Criteria Development
Sindhu R. Johnson¹, Dinesh Khanna², Ricard Cervera³, Nathalie Costedoat-Chalumeau⁴, Dafna D. Gladman⁵, Bevra H. Hahn⁶, Falk Hiepe⁷, Jorge Sanchez-Guerrero⁸, Elena Massarotti⁹, Dimitrios Boumpas¹⁰, Karen H. Costenbader¹¹, David I. Daikh¹², David Jayne¹³, Thomas Dörner¹⁴, Diane L. Kamen¹⁵, Marta Mosca¹⁶, Rosalind Ramsey-Goldman¹⁷, Josef S. Smolen¹⁸, David Wofsy¹⁹ and Martin Aringer²⁰, ¹Division of Rheumatology, Toronto Western Hospital, Mount Sinai Hospital, Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, ON, Canada, ²University of Michigan, Ann Arbor, MI, ³Department of Autoimmune Diseases, Hospital Clinic, Barcelona, Spain, ⁴Internal Medicine, Cochin University Hospital, Paris, France, ⁵Rheumatology, Centre for Prognosis Studies in the Rheumatic Diseases, Toronto Western Hospital and University of Toronto, Toronto, ON, Canada, ⁶Division of Rheumatology, UCLA David Geffen School of Medicine, Los Angeles, CA, ⁷Charité – Universitätsmedizin, Berlin, Germany, ⁸University of Toronto, Toronto, Canada; Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico city, Mexico, ⁹Rheumatology, Immunology, & Allergy, Harvard Medical School, Brigham & Women's Hosp, Boston, MA, ¹⁰University of Athens, Athens, Greece, ¹¹Rheumatology, Immunology and Allergy, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, ¹²Rheumatology, UCSF/VA Medical Center, San Francisco, CA, ¹³Medicine, Addenbrooke's Hospital, Cambridge, United Kingdom, ¹⁴Department of Medicine/Rheumatology and Clinical Immunology, Charité University Hospital, Berlin, Germany, ¹⁵Medicine/Rheumatology & Immunology, Medical University of South Carolina, Charleston, SC, ¹⁶Clinical and Experimental Medicine, University of Pisa, Rheumatology Unit, Pisa, Italy, ¹⁷FSM, Northwestern University, Chicago, IL, ¹⁸Medical University of Vienna and Hietzing Hospital, Vienna, Austria, ¹⁹University of California, San Francisco, San Francisco, CA, ²⁰Medicine III, University Medical Center and Faculty of Medicine at the TU Dresden, Dresden, Germany
Background/Purpose: Criteria for the classification of SLE are being developed with the support of EULAR and ACR. Two independent exercises (expert-based Delphi exercise and data-driven…
Abstract Number: 746 • 2015 ACR/ARHP Annual Meeting
Multi-Center Delphi Exercise Reveals Important Key Items in Classifying SLE
Bimba F. Hoyer¹, Gabriela Schmajuk², Martin Aringer³, Sindhu R. Johnson^4,5, David I. Daikh⁶, Thomas Dorner⁷ and on behalf of the SLE criteria steering committee, ¹Charité University Medicine, Department of Medicine/Rheumatology and Clinical Immunology and German Rheumatism Research Centre Berlin (DRFZ), Berlin, Germany, ²San Francisco VA Medical Center, University of California, San Francisco, San Francisco, CA, ³Rheumatology, Medicine III, University Clinical Center, Technical University Dresden, Dresden, Germany, ⁴Medicine, Toronto Scleroderma Program, Toronto Western Hospital, Toronto General Hospital, Mount Sinai Hospital, and University of Toronto, Toronto, ON, Canada, ⁵Dept of Rheumatology, Toronto Western and Mt. Sinai Hospitals, University of Toronto, Toronto, ON, Canada, ⁶Rheumatology, UCSF/VA Medical Center, San Francisco, CA, ⁷Department of Medicine/Rheumatology and Clinical Immunology and German Rheumatism Research Centre Berlin (DRFZ), Charité University Medicine, Berlin, Germany
Background/Purpose: EULAR and ACR have jointly funded a project to improve existing classification criteria for SLE; this abstract reports on the early phase of this…
Abstract Number: 775 • 2015 ACR/ARHP Annual Meeting
Identification of Candidate Items for Revised Classification Criteria for Systemic Lupus Erythematosus
Gabriela Schmajuk¹, Bimba F. Hoyer², Martin Aringer³, Sindhu R. Johnson⁴, Thomas Dorner⁵, David I. Daikh⁶ and SLE Classification Criteria Steering Committee, ¹San Francisco VA Medical Center, University of California, San Francisco, San Francisco, CA, ²Charité University Medicine, Department of Medicine/Rheumatology and Clinical Immunology and German Rheumatism Research Centre Berlin (DRFZ), Berlin, Germany, ³Rheumatology, Medicine III, University Clinical Center, Technical University Dresden, Dresden, Germany, ⁴Dept of Rheumatology, Toronto Western and Mt. Sinai Hospitals, University of Toronto, Toronto, ON, Canada, ⁵Charité – Universitätsmedizin, Berlin, Germany, ⁶Rheumatology, UCSF/VA Medical Center, San Francisco, CA
Background/Purpose: EULAR and ACR have jointly funded a project to improve existing classification criteria for SLE; this abstract reports on the early phase of this…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].